SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-035119
Filing Date
2020-06-08
Accepted
2020-06-08 19:08:53
Documents
1
Period of Report
2020-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4167
  Complete submission text file 0001209191-20-035119.txt   5551
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Issuer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 28 OVERLOOK DRIVE BEDFORD MA 01730
Business Address
TOMSICEK MICHAEL JOHN (Reporting) CIK: 0001570392 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38899 | Film No.: 20950487